PRECISION BIOSCIENCES INC (DTIL): debt financing — Precision BioSciences extends term loan maturity to Dec 31, 2029 via amendment with Banc of California

PRECISION BIOSCIENCES INC

Term loan maturity extended from June 30, 2027 to December 31, 2029.
No changes to principal amount, interest rate, or other loan terms disclosed.
Amendment executed on June 10, 2026; Banc of California is the lender.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.95

PRECISION BIOSCIENCES INC amended term loan of Term Loan under the Loan and Security Agreement with Banc of California at Existing interest rate (no change) maturing Extended from June 30, 2027 to December 31, 2029.

Instrument: term loan
Principal: Term Loan under the Loan and Security Agreement
Counterparty: Banc of California
Rate: Existing interest rate (no change)
Maturity: Extended from June 30, 2027 to December 31, 2029
Event: amendment

Exact text from the filing

The First Amendment extended the maturity date of the Term Loan (as defined in the Loan and Security Agreement) from June 30, 2027, to December 31, 2029.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

PRECISION BIOSCIENCES INC amended First Amendment to Amended and Restated Loan and Security Agreement with Banc of California (effective 2026-06-10).

Action: amendment
Agreement: credit facility
Counterparty: Banc of California
Effective: 2026-06-10

Exact text from the filing

On June 10, 2026, Precision BioSciences, Inc. (the “Company”) and Banc of California (the “Lender”) entered into a First Amendment to Amended and Restated Loan and Security Agreement (the “First Amendment”).

View on SEC.gov

296 debt financings filed in the last 30 days. Browse all debt financings →

PRECISION BIOSCIENCES INC filing history →

Source: SEC EDGAR

accession 0001628280-26-043526

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.